Trump appears to be simultaneously criticizing inversion mergers that shift
drug companies» tax domiciles overseas, pharma's
tactic of using manufacturing plants in European, Asian, and African countries, and high
drug prices.
Since the late 1990s, Huntingdon Life Sciences — a
company that conducts testing
of substances on animals mandated by the Environmental Protection Agency and the Food and
Drug Administration — has become a proving ground for increasingly aggressive
tactics by animal - rights militants.